Time course of onset, incidence and prevalence of gastrointestinal adverse events with HTD1801 (Berberine Ursodeoxycholate) in patients with MASH and T2DM

Authors
Category Primary study
JournalJ. Hepatol.
Year 2024
This article has no abstract
Epistemonikos ID: 5efa00bd6a5093748a38ac8098e35e8375975793
First added on: Aug 30, 2025